RK Damani’s Derive Investments buys 26.5 lakh shares of Fortis Healthcare

NEW DELHI: RK Damani’s Derive Investments on Monday bought 26.5 lakh shares of Fortis Healthcare.

The firm bought 26,58,843 shares of Fortis Healthcare at Rs 144.50 apiece in a bulk deal, NSE data showed.

Shares of Fortis Healthcare on Monday gained over 7 per cent to settle at Rs 147.60 apiece on NSE.

Earlier this month, Delhi High Court allowed Daiichi Sankyo to enforce an international arbitration award so that it could recover Rs 3,500 crore from Fortis Healthcare’s promoters Malvinder Singh and Shivinder Singh, marking a victory for the Japanese company. Days after the verdict, Singh brothers quit the Fortis board.

In the latest development, the government has ordered a Serious Fraud Investigation Office (SFIO) probe against Fortis Healthcare and Religare Enterprises, which are at the centre of a controversy involving accusations of misconduct against their promoters Malvinder and Shivinder Singh, said a TNN report.

However, in a clarification submitted to BSE on Monday, the company said it had not received any such communication from government authority.

  • Related Posts

    Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

    AiMeD welcomes the move long overdue to boost India’s Regulatory Framework New Delhi: 21 Drug Inspectors have been promoted to Assistant Drugs Controllers (India) under CDSCO. It was long unmet…

    Yashoda Medicity lifts Benchmark in Critical Care to New High

    With the introduction of North India’s first Advanced VitalGo Total Lift Bed Technology Ghaziabad/ New Delhi: In an ideal hospital, critical care is most paramount and it is also the…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    ICT Mumbai to host official launch of RasayanAI, bringing AI-powered drug discovery to researchers

    ICT Mumbai to host official launch of RasayanAI, bringing AI-powered drug discovery to researchers

    Six fake doctors arrested in Hyderabad

    Six fake doctors arrested in Hyderabad